Vident Investment Advisory, LLC Amgen Inc Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1.56 Million - $1.84 Million	-7,275 Reduced 10.23%	63,822 $14.2 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $378,424 - $461,235	-1,676 Reduced 2.3%	71,097 $17.2 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.19 Million - $2.79 Million	9,582 Added 15.16%	72,773 $19.1 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.09 Million - $1.23 Million	-4,844 Reduced 7.12%	63,191 $13.9 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.03 Million - $1.15 Million	4,480 Added 7.05%	68,035 $16.5 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $753,850 - $833,955	3,438 Added 5.72%	63,555 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $3.26 Million - $3.73 Million	16,369 Added 37.42%	60,117 $13.5 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $2.02 Million - $2.37 Million	9,529 Added 27.85%	43,748 $9.3 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $1.16 Million - $1.29 Million	4,966 Added 16.98%	34,219 $8.34 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $733,856 - $855,190	3,307 Added 12.75%	29,253 $7.28 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $878,935 - $1.05 Million	4,062 Added 18.56%	25,946 $5.97 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $129,996 - $144,566	554 Added 2.6%	21,884 $5.56 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $8.58 Million - $10.5 Million	-43,369 Reduced 67.03%	21,330 $5.03 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $8.94 Million - $11 Million	45,201 Added 231.82%	64,699 $15.3 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $2.04 Million - $2.7 Million	11,179 Added 134.38%	19,498 $3.95 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $220,051 - $282,841	1,163 Added 16.25%	8,319 $2.01 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $293,027 - $351,107	1,683 Added 30.75%	7,156 $1.39 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $2.01 Million - $2.36 Million	-12,086 Reduced 68.83%	5,473 $1.01 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $1.95 Million - $2.2 Million	10,781 Added 159.06%	17,559 $3.34 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $274,736 - $320,705	1,540 Added 29.4%	6,778 $1.32 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $558,464 - $629,594	3,014 Added 135.52%	5,238 $1.09 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $54,464 - $61,175	328 Added 17.3%	2,224 $410,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $251,264 - $293,634	-1,483 Reduced 43.89%	1,896 $326,000
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $815,424 - $911,078	-4,831 Reduced 58.84%	3,379 $588,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.37 Million - $1.57 Million	8,210	8,210 $1.53 Million

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account